These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 35220659)

  • 41. Health-related quality of life is dynamic in alcoholic hepatitis and responds to improvement in liver disease and reduced alcohol consumption.
    Madathanapalli A; Tang Q; Lammert C; Samala N; Shah VH; Sanyal A; Chalasani N; Desai AP
    Alcohol Clin Exp Res; 2022 Feb; 46(2):252-261. PubMed ID: 34862610
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Therapeutic plasma exchange is a safe and effective bridge therapy in patients with alcohol-associated ACLF not having immediate prospects for liver transplantation-A case-control, pilot study.
    Ramakrishnan S; Hans R; Duseja A; Sharma RR
    J Clin Apher; 2022 Dec; 37(6):553-562. PubMed ID: 36065827
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prognostic factors in severe alcoholic liver injury. Nara Liver Study Group.
    Fujimoto M; Uemura M; Kojima H; Ishii Y; Ann T; Sakurai S; Okuda K; Noguchi R; Adachi S; Kitano H; Hoppo K; Higashino T; Takaya A; Fukui H
    Alcohol Clin Exp Res; 1999 Apr; 23(4 Suppl):33S-38S. PubMed ID: 10235276
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Steroid treatment in patients with acute-on-chronic liver failure precipitated by hepatitis B: A 10-year cohort study in a university hospital in East China.
    Huang C; Yu KK; Zheng JM; Li N
    J Dig Dis; 2019 Jan; 20(1):38-44. PubMed ID: 30515980
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Predictors of 90-day mortality in patients with severe alcoholic hepatitis: Experience with 183 patients at a tertiary care center from India.
    Daswani R; Kumar A; Anikhindi SA; Sharma P; Singla V; Bansal N; Arora A
    Indian J Gastroenterol; 2018 Mar; 37(2):141-152. PubMed ID: 29704174
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Low-dose rifaximin prevents complications and improves survival in patients with decompensated liver cirrhosis.
    Zeng X; Sheng X; Wang PQ; Xin HG; Guo YB; Lin Y; Zhong JW; He CZ; Yin J; Liu TT; Ma WJ; Xiao X; Shi PM; Yuan ZL; Yang L; Ma X; Xu JM; Shen XZ; Yang CQ; Zhu X; Lv NH; Xie WF
    Hepatol Int; 2021 Feb; 15(1):155-165. PubMed ID: 33385299
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Infections complicating severe alcoholic hepatitis: Enterococcus species represent the most frequently identified pathogen.
    Beisel C; Blessin U; Schulze Zur Wiesch J; Wehmeyer MH; Lohse AW; Benten D; Kluwe J
    Scand J Gastroenterol; 2016 Jul; 51(7):807-13. PubMed ID: 27000534
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-term administration of rifaximin improves the prognosis of patients with decompensated alcoholic cirrhosis.
    Vlachogiannakos J; Viazis N; Vasianopoulou P; Vafiadis I; Karamanolis DG; Ladas SD
    J Gastroenterol Hepatol; 2013 Mar; 28(3):450-5. PubMed ID: 23216382
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Worsening Profile of Alcoholic Hepatitis in the United States.
    Nguyen TA; DeShazo JP; Thacker LR; Puri P; Sanyal AJ
    Alcohol Clin Exp Res; 2016 Jun; 40(6):1295-303. PubMed ID: 27147285
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Case Report: Acute-on-Chronic Liver Failure: Making the Diagnosis between Infection and Acute Alcoholic Hepatitis.
    Sendra C; Ampuero J; Gallego ÁG; Sousa JM; Jiménez MS; Romero-Gómez M
    Semin Liver Dis; 2016 May; 36(2):181-6. PubMed ID: 27172361
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Assessment of scoring systems for acute-on-chronic liver failure at predicting short-term mortality in patients with alcoholic hepatitis.
    Kim HY; Kim CW; Kim TY; Song DS; Sinn DH; Yoon EL; Jung YK; Suk KT; Lee SS; Lee CH; Kim TH; Kim JH; Yim HJ; Kim SE; Baik SK; Lee BS; Jang JY; Kim YS; Kim SG; Yang JM; Sohn JH; Lee HJ; Park SH; Choi EH; Kim DJ;
    World J Gastroenterol; 2016 Nov; 22(41):9205-9213. PubMed ID: 27895407
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognosis of treated severe alcoholic hepatitis in patients with gastrointestinal bleeding.
    Rudler M; Mouri S; Charlotte F; Lebray P; Capocci R; Benosman H; Poynard T; Thabut D
    J Hepatol; 2015 Apr; 62(4):816-21. PubMed ID: 25450199
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Predictors of mortality among patients with compensated and decompensated liver cirrhosis: the role of bacterial infections and infection-related acute-on-chronic liver failure.
    Sargenti K; Prytz H; Nilsson E; Kalaitzakis E
    Scand J Gastroenterol; 2015 Jul; 50(7):875-83. PubMed ID: 25697824
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characteristics and risk factors of infections in patients with HBV-related acute-on-chronic liver failure: a retrospective study.
    Zhang Q; Shi B; Wu L
    PeerJ; 2022; 10():e13519. PubMed ID: 35811816
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Rifaximin reduces the incidence of spontaneous bacterial peritonitis, variceal bleeding and all-cause admissions in patients on the liver transplant waiting list.
    Salehi S; Tranah TH; Lim S; Heaton N; Heneghan M; Aluvihare V; Patel VC; Shawcross DL
    Aliment Pharmacol Ther; 2019 Aug; 50(4):435-441. PubMed ID: 31169941
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Acute kidney injury in hepatitis B-related acute-on-chronic liver failure without preexisting liver cirrhosis.
    Huang Z; Lin C; Fang J; Wang N; Zhou R; Pan C
    Hepatol Int; 2015 Jul; 9(3):416-23. PubMed ID: 25980390
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of pretransplant rifaximin therapy on early post-liver transplant infections.
    Esfeh JM; Hanouneh IA; Koval CE; Kovacs C; Dalal DS; Ansari-Gilani K; Confer BD; Eghtesad B; Zein NN; Menon KV
    Liver Transpl; 2014 May; 20(5):544-51. PubMed ID: 24493238
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical Course and Risk Factors for Infection in Severe Forms of Alcohol-Associated Liver Disease.
    Otero Sanchez L; Karakike E; Njimi H; Putignano A; Degré D; Hites M; Jacobs F; Moreno C; Trepo E; Gustot T
    Hepatology; 2021 Nov; 74(5):2714-2724. PubMed ID: 34046927
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Plasma endotoxin and serum cytokine levels in patients with alcoholic hepatitis: relation to severity of liver disturbance.
    Fujimoto M; Uemura M; Nakatani Y; Tsujita S; Hoppo K; Tamagawa T; Kitano H; Kikukawa M; Ann T; Ishii Y; Kojima H; Sakurai S; Tanaka R; Namisaki T; Noguchi R; Higashino T; Kikuchi E; Nishimura K; Takaya A; Fukui H
    Alcohol Clin Exp Res; 2000 Apr; 24(4 Suppl):48S-54S. PubMed ID: 10803780
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparative Effectiveness of Pharmacological Interventions for Severe Alcoholic Hepatitis: A Systematic Review and Network Meta-analysis.
    Singh S; Murad MH; Chandar AK; Bongiorno CM; Singal AK; Atkinson SR; Thursz MR; Loomba R; Shah VH
    Gastroenterology; 2015 Oct; 149(4):958-70.e12. PubMed ID: 26091937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.